The association between cyclin E gene amplification and BRCA1/2 mutations have been examined previously and in studies with high grade serous ovarian cancer, such associations were found to be mutually exclusive [58,59]. The gene discussed is CCNE1; the disease is ovarian serous adenocarcinoma.